(Q38273909)

1 September 2017

1 reference

title

Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder (English)

1 reference

1 September 2017

main subject

autism spectrum disorder

0 references

0 references

1 reference

1 reference

Richard E Frye

1

0 references

publication date

4 November 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

47

1 reference

1 September 2017

page(s)

147-157

1 reference

Gastrointestinal problems in children with autism, developmental delays or typical development

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

ADHD and autism: differential diagnosis or overlapping traits? A selective review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cognitive-behavioral therapy for anxiety in children with high-functioning autism: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The incidence of seizures among children with autistic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Seizure disorders in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism and epilepsy: a retrospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Medically refractory epilepsy in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Epilepsy, autism, and neurodevelopment: kindling a shared vulnerability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism and social cognition in epilepsy: implications for comprehensive epilepsy care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

NINDS epilepsy and autism spectrum disorders workshop report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Recent developments in the genetics of autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cerebral folate receptor autoantibodies in autism spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Abnormalities of cholesterol metabolism in autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Neurometabolic disorders and dysfunction in autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Impaired mitochondrial function in psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The psychiatric manifestations of mitochondrial disorders: a case and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial disease and epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The role of mitochondria in epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial involvement in temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Review of clinical trials for mitochondrial disorders: 1997-2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Disorders of creatine transport and metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Creatine deficiency syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Smith-Lemli-Opitz syndrome and autism spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Smith-Lemli-Opitz syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism: the role of cholesterol in treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress-related biomarkers in autism: systematic review and meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Aberrations in folate metabolic pathway and altered susceptibility to autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese Han population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Population- and family-based studies associate the MTHFR gene with idiopathic autism in simplex families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The MTHFR 677C-->T polymorphism and behaviors in children with autism: exploratory genotype-phenotype correlations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autoantibodies to folate receptors in the cerebral folate deficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial complex I encephalomyopathy and cerebral 5-methyltetrahydrofolate deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cerebral folate deficiency and CNS inflammatory markers in Alpers disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cerebral Folate Deficiency Syndromes in Childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial diseases associated with cerebral folate deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Fever plus mitochondrial disease could be risk factors for autistic regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Role of folate receptor autoantibodies in infantile autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Cerebral folate deficiency with developmental delay, autism, and response to folinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine-dependent seizures: a case report and a critical review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mutations in antiquitin in individuals with pyridoxine-dependent seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine-dependent seizures: findings from recent studies pose new questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Reduced GABA synthesis in pyridoxine-dependent seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine dependent seizures--a wider clinical spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine-dependent seizures, clinical and therapeutic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine-dependency seizure: report of a rare presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Effects of pyridoxine and magnesium on autistic symptoms--initial observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A 15-year follow-up of a boy with pyridoxine (vitamin B6)-dependent seizures with autism, breath holding, and severe mental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A case of partial biotinidase deficiency associated with autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Relative carnitine deficiency in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in autism spectrum disorders: cause or effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical aspects of the disorders of GABA metabolism in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Succinic semialdehyde dehydrogenase deficiency in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical spectrum of succinic semialdehyde dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Adenylosuccinate lyase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Misleading behavioural phenotype with adenylosuccinate lyase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Metabolic approaches to the treatment of autism spectrum disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Developmental disorder associated with increased cellular nucleotidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism and phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Decreased tryptophan metabolism in patients with autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Association of rs2129575 in the tryptophan hydroxylase 2 gene with clinical phenotypes of autism spectrum disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Association with tryptophan hydroxylase 2 gene polymorphisms and autism spectrum disorders in Korean families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Tryptophan hydroxylase 2 (TPH2) gene polymorphisms and psychiatric comorbidities in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Neuropsychiatric manifestations in late-onset urea cycle disorder patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Current concepts in the pathogenesis of urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Deficits in bioenergetics and impaired immune response in granulocytes from children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial abnormalities in temporal lobe of autistic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Brain region-specific altered expression and association of mitochondria-related genes in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Downregulation of the expression of mitochondrial electron transport complex genes in autism brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Redox metabolism abnormalities in autistic children associated with mitochondrial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in autistic patients with 15q inverted duplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Developmental regression and mitochondrial dysfunction in a child with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46,XY male with a de novo MECP2 gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial disease in 22q13 duplication syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Septo-optic dysplasia associated with a new mitochondrial cytochrome b mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress and mitochondrial dysfunction in Down syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Autism: metabolism, mitochondria, and the microbiome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

CNS energy metabolism as related to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Excess of high frequency electroencephalogram oscillations in boys with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Development of neurotransmitter systems during critical periods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Regional differences in synaptogenesis in human cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Developmental changes in cerebral grey and white matter volume from infancy to adulthood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Research advances in basic mechanisms of seizures and antiepileptic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Analysis of glutathione: implication in redox and detoxification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress and epilepsy: literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The use of flavonoids in central nervous system disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Targeting oxidative stress component in the therapeutics of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Modulation of oxidative stress and mitochondrial function by the ketogenic diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The ketogenic diet for the treatment of glioma: insights from genetic profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Immune mechanisms in epileptogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Immunological and autoimmune considerations of Autism Spectrum Disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Wild-type microglia arrest pathology in a mouse model of Rett syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Immune signalling in neural development, synaptic plasticity and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondria as all-round players of the calcium game

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

5q14.3 deletion manifesting as mitochondrial disease and autism: case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Effect of a vitamin/mineral supplement on children and adults with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A preliminary trial of ascorbic acid as supplemental therapy for autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Ubiquinol improves symptoms in children with autism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Sexually dimorphic effects of prenatal exposure to propionic acid and lipopolysaccharide on social behavior in neonatal, adolescent, and adult rats: implications for autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

A new rat model for vulnerability to epilepsy and autism spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Ketogenic diet improves core symptoms of autism in BTBR mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Clinical presentation of mitochondrial disorders in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Neurologic presentations of mitochondrial disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

7 January 2021

Mitochondrial disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Oxidative stress in autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Environmental toxicants and autism spectrum disorders: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Short-term benefit from oral vancomycin treatment of regressive-onset autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Gastrointestinal microflora studies in late-onset autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial disease criteria: Diagnostic applications in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Mitochondrial disorders: clinical presentation and diagnostic dilemmas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.08.134

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2014.08.134

1 reference

1 September 2017

1 reference